NHS must treat patients with rare conditions fairly

We read Sophia Christie's article on collective commissioning with interest. Ms Christie clearly takes the view that no patient with a rare disease is worth treating, as drugs developed for such conditions have limited evidence and are very expensive due to high development costs. So much for the NHS being ...

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here